Life As Surplus - Biotechnology and Capitalism in the Neoliberal Era

Informationen zum Autor Melinda E. Cooper Klappentext From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with the growing internal contradictions of the commercialized life sciences. Melinda Cooper is a research fellow with the Centre for Biomedicine and Society, Kings College London. Zusammenfassung Focusing on the period from 1970s onwards! this is a study of the relationship between politics! economics! science! and cultural values in the United States. It demonstrates that the history of biotechnology cannot be understood without taking into account the simultaneous rise of neo-liberalism as a political force and an economic policy. Inhaltsverzeichnis Acknowledgments Introduction 1. Life Beyond the Limits: Inventing the Bioeconomy 2. On Pharmaceutical Empire: AIDS, Security, and Exorcism 3. Preempting Emergence: The Biological Turn in the War on Terror Intermezzo 4. Contortions: Tissue Engineering and the Topological Body 5. Labors of Regeneration: Stem Cells and the Embryoid Bodies of Capital 6. The Unborn Born Again: Neo-Imperialism, the Evangelical Right, and the Culture of Life Epilogue Notes References Index

Product details

• Authors: Melinda Cooper, Melinda E Cooper, Melinda E. Cooper
• Publisher: University Of Washington Press
• Languages: English
• Product format: Paperback / Softback
• Released: 15.05.2008
• EAN: 9780295987910
• ISBN: 978-0-295-98791-0
• No. of pages: 208
• Dimensions: 178 mm x 230 mm x 15 mm
• Series: In Vivo; In Vivo: The Cultural Mediations of Biomedical Science; In Vivo: The Cultural Mediations of Biomedical Science; IN VIVO; In Vivo: The Cultural Mediatio; Life as Surplus; In Vivo: the Cultural Mediations of Biomedical ScienceIn Vivo: the Cultural Mediations of Biomedical ScienceIn Vivo: the Cultural Mediations of Biomedical ScienceIn Vivo: the Cultural Mediations of Bi
• Subjects: Natural sciences, medicine, IT, technology > Natural sciences (general); Social sciences, law, business > Business